Radiation Oncology/RTOG Trials/0415
< Radiation Oncology < RTOG TrialsRTOG 04-15 (PROSTATE)
- Title: A Phase III Randomized Study of Hypofractionated 3D-CRT/IMRT Versus Conventionally Fractionated 3D-CRT/IMRT in Patients With Favorable-Risk Prostate Cancer
- Objective: Compare the disease-free survival (DFS) of patients with favorable-risk stage II prostate cancer treated with hypofractionated vs conventionally fractionated three-dimensional conformal radiotherapy (3D-CRT) or intensity-modulated radiotherapy (IMRT).
- Protocol:
- Arm 1: 73.8 Gy in 41 fractions
- Arm 2: 70 Gy in 28 fractions
- Eligibility:
- T1-2c N0 M0, Gleason 2-6, PSA < 10
- Enrollment Target: 1067 patients
- Activated: April 18, 2006
- Closed: December 11, 2009
- Clinicaltrials.gov
This article is issued from Wikibooks. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.